In cytology practice, breast cancer is most commonly seen as a metastatic diagnosis.

• A. Metastatic diagnosis
• B. Primary diagnosis
• C. Unknown
• D. Both equally

Answer: (A)

In cytology, the most common scenario you’ll encounter with breast cancer is identifying metastatic disease rather than diagnosing a new primary tumor. Cytology is highly effective for quickly confirming the presence of malignant cells in samples from sites of spread—such as regional lymph nodes or distant sites like the pleura, peritoneum, liver, or lungs. These samples are taken to stage cancer and guide treatment, so metastatic breast cancer shows up frequently on cytology slides.

Distinguishing a primary breast carcinoma usually relies on tissue architecture and context that are best preserved in histology from a core needle or excisional biopsy. While cytology can recognize malignant cells from a breast origin, confirming that those cells represent a primary breast tumor versus a metastasis from another site often requires additional information and, sometimes, immunocytochemical markers. That combination makes metastatic disease the more common cytology diagnosis for breast cancer.